Oppenheimer Holdings heads into its Q1 2026 results — due this morning — with one of the most striking divergences in its recent history: short sellers have nearly doubled their bets against the stock over the past month, yet the shares are up 26% in the same period.
Short interest has been the dominant story in OPY's lending market. Estimated short positions have grown roughly 73% over the past 30 days, rising from around 22,000 shares in mid-March to just over 41,000 as of April 28. That is a sustained build, not a single-day spike — the count has climbed on almost every reading since early April. The catalyst is visible in the news flow: on April 24, Oppenheimer announced a $70 million settlement of its FDIC "cash sweep" class action, filing an 8-K to confirm the deal. Shorts appear to have been positioning around that legal overhang throughout the month, ramping exposure as the settlement moved closer to resolution. Despite the build, the absolute level of borrowing remains tiny relative to the float, and availability in the lending pool is very loose — the borrow market shows no signs of stress or squeeze dynamics. Cost to borrow has roughly doubled over the week to 0.54%, but at that level it remains effectively free for most short-sellers.
Options positioning tells the opposite story. Call volume is dramatically dominant right now, with the put/call ratio at just 0.08 — well below its 20-day average of 0.19 and near the lowest reading of the past year. The 52-week high on the PCR was 0.74, hit in early April during the tariff-driven selloff. Since then, buyers of upside have taken control. That flip in options sentiment tracks the stock's own trajectory: OPY has gained 26% over the past month to close Wednesday at $110.55, even as the settlement news removed a chunk of balance-sheet certainty. The divergence between a growing short book and aggressively bullish options flow sets up a charged backdrop for this morning's print.
The earnings history adds texture to that setup. The most recent comparable — the January 30 release — produced a 17% single-day gain followed by a 21% five-day move. The October 2025 print went the other way, with a 3.2% one-day drop. The pattern across the last few events is asymmetric: the big moves have been to the upside. With the stock already near a 52-week high and options leaning hard toward calls, today's release is less about whether the settlement was priced in and more about whether the underlying business — advisory revenues, capital markets activity — can justify a share price that has retraced sharply from the lows of early April.
On ownership, the picture underscores how concentrated and founder-heavy OPY is. Chairman and CEO Albert Lowenthal holds roughly 32.5% of shares. His son Robert Lowenthal, a director, received a 35,505-share equity award in January. The most recent open-market transaction was a March 2 sale of 4,673 shares by Company Secretary Dennis McNamara at $90.67 — a price that now looks well below the current level. Institutional names including Dimensional Fund Advisors, Vanguard, and BlackRock hold modest stakes of around 1.6–4.6%, leaving the float thin and the stock susceptible to sharp moves on volume. Peers saw a rough week: EVR fell nearly 8% over seven days and PIPR dropped around 3%, while AMP was roughly flat. OPY's 4.6% weekly decline puts it broadly in line with its investment-banking peers, though the month-long rally sets it apart from the group.
The factor scores add one more layer of interest. OPY's dividend score ranks in the 95th percentile — a standout, even though the dividend history in the data runs stale to 2022. The short score of 27 places it in the 87th percentile among comparable names, reflecting the recent surge in estimated short positioning relative to its own history. The RSI at 63 is elevated but not overbought. What to watch after the opening bell: whether Q1 revenues from capital markets and advisory confirm the post-January momentum, and how management characterises the net financial impact of the $70 million cash sweep settlement on the balance sheet.
See the live data behind this article on ORTEX.
Open OPY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
